We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Newborn Screening Laboratory definition

Newborn Screening Laboratory means a laboratory operated by the Department or a laboratory certified by the Department to conduct the tests and carry out the follow-up required by these procedures.
Sample 1Sample 2Sample 3
Newborn Screening Laboratory means an entity contracted with the Department under A.R.S. § 36-694(C) to per- form the newborn screening test.
Sample 1Sample 2
Newborn Screening Laboratory means a laboratory operated by the
Sample 1

Examples of Newborn Screening Laboratory in a sentence

  • Newborn Screening Laboratory results have important implications for all children born in the State of Michigan.

  • It is then sent to the National Newborn Screening Laboratory in Queen Elizabeth University Hospital for analysis.

  • Authorized providers can access newborn screening results on-line through the State Electronic Notification Surveillance System (SendSS) or DPH Newborn Screening Laboratory web portal (eReports): https://services.georgia.gov/dph/eReports/.

  • The function of the Newborn Screening Laboratory is to ensure the health and well-being of all infants born in the State of Michigan as mandated by Michigan law and accepted medical practice.

  • Confirmation of the appointment (and diagnosis, when available) should be sent to the Scottish Newborn Screening Laboratory.

  • These consumables must be compatible with the PE Corp/Applied Biosystems instruments currently in use in the Newborn Screening Laboratory of the BOL.

  • The demographic information collected at the time of pulse oximetry screening will be used to match the infant’s CCHD screening results to the blood spot card sent to theMDHHS Newborn Screening Laboratory.

  • Work has progressed on these recommendations specific to screening for metabolic disorders.Subsequent to 1993 representation was made by the Director of the National Newborn Screening Laboratory (NNSL) to the Department of Health and Children highlighting concerns regarding certain aspects of the programme particularly in relation to overall responsibility for theprogramme.

  • The Colorado Newborn Screening Laboratory complies with the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

  • The hospital shall implement a procedure to assure that a newborn screening specimen has been collected on every newborn and mailed to the Newborn Screening Laboratory within twenty four to forty-eight (24 – 48) hours of collection.


More Definitions of Newborn Screening Laboratory

Newborn Screening Laboratory means a laboratory with which the Department contracts to conduct testing of the newborn screening specimens.
Sample 1

Related to Newborn Screening Laboratory

  • Testing laboratory means a laboratory, facility, or entity in the state that offers or performs tests of cannabis or cannabis products and that is both of the following:

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Independent testing laboratory means an independent organization, accepted by the Contracting Officer, engaged to perform specific inspections or tests of the work, either at the site or elsewhere, and report the results of these inspections or tests.

  • Health screening means the use of one or more diagnostic tools to test a person for the presence or precursors of a particular disease.

  • Approved laboratory means a laboratory that is listed in the national conference of interstate milk shipments list of sanitation compliance and enforcement ratings distributed by the United States food and drug administration and as approved by the director.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • Dental laboratory means a person, firm or corporation

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Screening means the process to determine whether the person seeking assistance needs further comprehensive assessment.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Screening Test Technician (STT) means anyone who instructs and assists individuals in the alcohol testing process and operates an ASD.

  • Laboratory or “LANL” means the geographical location of Los Alamos National Laboratory, a federally funded research and development center owned by the DOE / NNSA.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Certified laboratory means a laboratory that is on an approved list issued by us.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Non-Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Diagnosis means the definition of the nature of the Client's disorder. When formulating the Diagnosis of Client, CONTRACTOR shall use the diagnostic codes and axes as specified in the most current edition of the DSM published by the American Psychiatric Association. DSM diagnoses will be recorded on all IRIS documents, as appropriate.

  • Alcohol Screening Device (ASD) means a breath or saliva device, other than an Evidential Breath Testing Device (EBT), that is approved by the National Highway Traffic Safety Administration and placed on its Conforming Products List for such devices.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Healing arts screening means the testing of human beings using x-ray machines for the detection or evaluation of health indications when such tests are not specifically and individually ordered by a licensed practitioner of the healing arts legally authorized to prescribe such x-ray tests for the purpose of diagnosis or treatment.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

Most Referenced Clauses

Most Referenced Definitions